INM
InMed Pharmaceuticals IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$2.48M
P/E Ratio
—
EPS
$-3.02
Beta
0.57
52W High
$5.50
52W Low
$0.57
50-Day MA
$0.76
200-Day MA
$1.50
Dividend Yield
—
Profit Margin
-170.10%
Forward P/E
—
PEG Ratio
—
About InMed Pharmaceuticals Inc
InMed Pharmaceuticals Inc., a clinical-stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company is headquartered in Vancouver, Canada.
Fundamentals
| Revenue (TTM) | $4.51M |
| Gross Profit (TTM) | $1.34M |
| EBITDA | $-7.63M |
| Operating Margin | -258.60% |
| Return on Equity | -97.20% |
| Return on Assets | -49.80% |
| Revenue/Share (TTM) | $1.72 |
| Book Value | $3.42 |
| Price-to-Book | 0.25 |
| Price-to-Sales (TTM) | 0.55 |
| EV/Revenue | 0.282 |
| EV/EBITDA | 0.51 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -26.20% |
| Shares Outstanding | $3.31M |
| Float | $2.16M |
| % Insiders | 0.12% |
| % Institutions | 9.43% |
Historical Volatility
HV 10-Day
61.45%
HV 20-Day
61.36%
HV 30-Day
68.20%
HV 60-Day
81.13%
HV Rank
—
Volatility is currently contracting
More HEALTHCARE Stocks
Data last updated: 5/5/2026